Weekly spin class ‘better than physio' for people with common hip issue
Hip osteoarthritis happens when the cartilage in the hip breaks down, causing pain and stiffness.
It it estimated that the condition affects about 3.2 million people in the UK.
For the trial, experts from Bournemouth University and University Hospitals Dorset (UHD) compared usual physiotherapy care with an eight-week exercise and education programme known as Chain (cycling against hip pain).
The study, published in The Lancet Rheumatology, included 211 people, with roughly half assigned to each group.
The Chain group attended weekly education sessions from a physiotherapist, lasting around 30 minutes, followed by a 30-minute session of static cycling led by a gym instructor.
The effects of treatment on patients were measured by the Hip Disability and Osteoarthritis Outcome Score (HOOS) activities of daily living (ADL) subscale, which assesses how hip problems affect various daily activities.
The study found those who completed the cycling classes had a 'statistically significant improvement in patient-reported function after treatment'.
Researchers said the method 'showed superior outcomes compared with usual physiotherapy care, and the feasibility of delivering a low-cost, community-based intervention within the NHS was shown'.
However, they stress the 'longer-term benefits and broader generalisability warrant further investigation'.
Tom Wainwright, a professor of orthopaedics at Bournemouth University and a physiotherapist at UHD, said: 'For the time it takes to treat one patient using standard physiotherapy, we can treat multiple patients in a group session and provide them with better outcomes.
'This has proved to be more cost-effective than standard treatment and so we hope this will contribute to reducing NHS waiting times for physiotherapy treatment in the future.'
Professor Rob Middleton, of Bournemouth University and an orthopaedic surgeon at UHD, said: 'Hip replacements cost the NHS over £6,000 per patient, so avoiding surgery for hip problems reduces the burden on the NHS, saves money, and provides better outcomes for patients.
'Now with this new study we can also see the potential for static cycling to save further money for the NHS by bringing down waiting lists for physiotherapy.'
Dr Peter Wilson, chief medical officer at UHD, said: 'We are an ageing population and increasingly we are seeing more patients with osteoarthritis that need either surgery or physiotherapy.
'Finding alternative ways to treat these patients could help reduce waiting times and the financial demand on NHS services.'
The Chain intervention was first launched in 2013 and patients who wish to take part are referred to UHD from their GP.
To bolster access on a national level, experts from Bournemouth University had developed a virtual course on their education app, allowing people to follow the programme from their home or local gym.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
STV News
an hour ago
- STV News
Concern over weight gain after ‘skinny jabs'
Health chiefs have raised concerns about people regaining weight after using Wegovy and Mounjaro, saying that patients coming off the drugs should be given support to help prevent them piling on the pounds again. Research shows that many people regain weight after stopping treatment if they are not supported, the National Institute for Health and Care Excellence (Nice) said. The health watchdog said that people coming off the drugs should be offered 'structured advice and follow-up support' to help prevent weight gain. The guidance is for people who are offered the treatments through the NHS. An estimated 1.5 million people are taking weight loss jabs in the UK, but the vast majority are paying for them privately so will not be eligible for NHS support after they have finished their treatment. Around 240,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide, through the NHS over the next three years. The new 'quality standard' from Nice says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a 'sickness service' to a genuine health service focused on prevention.' Dr Rebecca Payne, chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Commenting, Henry Gregg, chief executive of the National Pharmacy Association, said: 'Pharmacies take their responsibilities seriously to provide full wrap-around support to patients trying to achieve a healthy weight. 'We know that although medication can be effective in speeding up weight loss in some people, it is not a silver bullet and patients need to make long-term lifestyle changes to make their weight loss sustainable. 'The current NHS rollout of weight loss treatment is very small, with only a handful of patients receiving it, and it will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
The Independent
an hour ago
- The Independent
What is RSV? The main cause of hospital admissions for children
Health experts say the UK should brace for a surge in a potentially serious virus following a record number of cases in Australia. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. In Australia, respiratory syncytial virus (RSV) cases have surged in recent months, and officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the vaccine, which protects against RSV, in order to protect their newborn babies. The virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said that while for most adults, RSV 'only causes mild, cold-like symptoms, for older adults and young children, it can lead to serious breathing problems that can end up in hospitalisation'. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab, and NHS England will start inviting people to come forward in the next few weeks. Symptoms of an RSV infection NHS RSV is a common cause of coughs and colds, but some people have a high risk of getting seriously ill from the virus, including babies and adults over the age of 75. In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab for pregnant women can prevent 72 per cent of hospital admissions for their babies. And the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, UKHSA said.
The Independent
an hour ago
- The Independent
Discovery in Arctic cave provides a ‘rare snapshot of a vanished world'
The remains of animals dating back more than 10,000 years have been found in a cave in northern Norway providing the oldest example of an animal community living in the European Arctic region. Forty-six types of mammals were found, as well as fish and birds. The discovery, which includes polar bear, walrus, bowhead whale and Atlantic puffin, provides 'a rare snapshot of a vanished Arctic world', according to scientists. Also found were the remains of collared lemmings which are now extinct in Europe and had not been found in Scandinavia before. The team say the study, published in the journal Proceedings of the National Academy of Sciences (PNAS), will help show how wildlife has responded to dramatic climate shifts in the past as the animal community dates to a warmer period of the ice age. DNA testing carried out for the research found that the lineages of the animals did not survive when colder conditions returned. Sam Walker, of Bournemouth University, said: 'These discoveries provide a rare snapshot of a vanished Arctic world. 'They also underscore how vulnerable cold-adapted species can be under changing climate conditions, which can help us to understand their resilience and extinction risk in the present.' The remains were found in the Arne Qvamgrotta cave which was first discovered in the 1990s when a local mining industry built a tunnel through the nearby mountain. But it was large excavations carried out in 2021 and 2022 which led to the discovery of the animals which also included common eider, rock ptarmigan and Atlantic cod. Professor Sanne Boessenkool, of the University of Oslo, said: 'We have very little evidence of what Arctic life was like in this period because of the lack of preserved remains over 10,000 years old. 'The cave has now revealed a diverse mix of animals in a coastal ecosystem representing both the marine and the terrestrial environment.' The researchers state that the variety of animals including migratory reindeer suggest the habitat would have been mostly ice-free at the time and the presence of freshwater fish meant there would have been lakes and rivers within tundra. There would also have been sea ice for the bowhead whales and walruses, although this would have been seasonal as the harbour porpoises found are known to avoid ice, the scientists say. The study suggests that although the animals had managed to colonise the region after the glaciers melted, their whole populations had died out as they had been unable to migrate when the ice returned. Dr Walker said: 'This highlights how cold-adapted species struggle to adapt to major climatic events. 'This has a direct link to the challenges they are facing in the Arctic today as the climate warms at a rapid pace. 'The habitats these animals in the region live in today are much more fractured than 75,000 years ago, so it is even harder for animal populations to move and adapt.' Prof Boessenkool added: 'It is also important to note that this was a shift to a colder, not a period of warming that we are facing today. 'And these are cold-adapted species, so if they struggled to cope with colder periods in the past, it will be even harder for these species to adapt to a warming climate.'
